↓ Skip to main content

Cochrane Database of Systematic Reviews

Chemotherapy wafers for high grade glioma

Overview of attention for article published in Cochrane database of systematic reviews, March 2011
Altmetric Badge

Mentioned by

twitter
1 tweeter
facebook
1 Facebook page

Citations

dimensions_citation
71 Dimensions

Readers on

mendeley
205 Mendeley
Title
Chemotherapy wafers for high grade glioma
Published in
Cochrane database of systematic reviews, March 2011
DOI 10.1002/14651858.cd007294.pub2
Pubmed ID
Authors

Michael G Hart, Ruth Garside, Gabriel Rogers, Margaret Somerville, Ken Stein, Robin Grant

Abstract

Standard treatment for high grade glioma (HGG) usually entails surgery (either biopsy or resection) followed by radiotherapy plus or minus temozolomide. Implanting wafers impregnated with chemotherapy agents into the resection cavity represents a novel means of delivering drugs directly to the resection cavity with potentially fewer systemic side effects. It is not clear how effective this modality is or whether it should be recommended as part of standard care for patients with HGG.

Twitter Demographics

The data shown below were collected from the profile of 1 tweeter who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 205 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United Kingdom 2 <1%
Nepal 1 <1%
Unknown 202 99%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 34 17%
Student > Master 28 14%
Student > Bachelor 27 13%
Researcher 25 12%
Student > Postgraduate 13 6%
Other 34 17%
Unknown 44 21%
Readers by discipline Count As %
Medicine and Dentistry 83 40%
Pharmacology, Toxicology and Pharmaceutical Science 16 8%
Nursing and Health Professions 14 7%
Agricultural and Biological Sciences 12 6%
Neuroscience 9 4%
Other 21 10%
Unknown 50 24%

Attention Score in Context

This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 25 March 2013.
All research outputs
#13,895,344
of 18,110,549 outputs
Outputs from Cochrane database of systematic reviews
#10,722
of 11,820 outputs
Outputs of similar age
#113,818
of 163,588 outputs
Outputs of similar age from Cochrane database of systematic reviews
#93
of 108 outputs
Altmetric has tracked 18,110,549 research outputs across all sources so far. This one is in the 20th percentile – i.e., 20% of other outputs scored the same or lower than it.
So far Altmetric has tracked 11,820 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 25.5. This one is in the 7th percentile – i.e., 7% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 163,588 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 26th percentile – i.e., 26% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 108 others from the same source and published within six weeks on either side of this one. This one is in the 12th percentile – i.e., 12% of its contemporaries scored the same or lower than it.